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Lymphocytes are essential in combating infections; they dis-
play powerful eﬀector mechanisms and their activity must be
regulated at all times to avoid self-tissue or cells destruction.
These immunological lineages are detected in protochordates
and vertebrates. Long-term hematopoietic cells originate,
in the bone marrow, all hematopoietic lineages, including
lymphocytes. B and T lymphocytes are responsible for
adaptive immune responses. Natural killer cells, NK, are also
considered a lymphocytic lineage; however, its development
is completely diﬀerent from that of lymphocytes. NK cells
display a diﬀerent set of receptors from those expressed
by B and T lymphocytes and are responsible for innate,
not adaptive responses against virus infected and tumor
cells. Finally, NKT cells are also lymphocytes generated in
the thymus through contact with glycolipid loaded CD1d-
presenting cells with a diverse function in modulating
immune responses against self- and foreign antigens.
Function of lymphocytes and its products range from
the neutralization of pathogens with specific antibodies
to the activation of macrophages and to direct cytotoxic
activity. Lymphocytes diﬀerentiate in primary lymphoid
organs where they commit a lymphocytic lineage, express B
or T cell receptors (BCR and TCR, resp.,), which are essential
for cell survival and further maturation as well as function,
and are selected according to their capacity of antigen
recognition. Virtually all antigens present or presented in
primary lymphoid organs are self-antigens. Lymphocytes
that express receptors with high aﬃnity to self-antigens
either trigger programmed cell death or diﬀerentiate into
regulatory cells (natural regulatory T cells). Lymphocytes
that succeed in expressing a functional receptor with low-
to-moderate aﬃnity to self-antigens emigrate to secondary
lymphoid organs, where they are exposed to foreign anti-
gens and may be activated to generate eﬀector responses
(Figure 1). While B cells develop, in mammals, in the bone
marrow, T cell progenitors migrate to the thymus to develop
to mature TCRalpha/beta CD4 and CD8 T cells, as well as
TCRgamma/delta T cells. During development in primary
lymphoid organs, lymphocytes depend on a series of signals
to pass through the checkpoints necessary to generate mature
cells. In all progenitor stages, interaction with the organ
stroma is important, but soluble factors as cytokines are
also important for the survival of progenitor cells, mainly
before B or T receptor expression. Y. Wanget al. review
the expression control and role of Bcl-xL, a protein that
promotes cell survival, in T cell development in the thymus
as well as in T cell activation in the periphery.
An interesting feature of lymphocyte progenitors that
migrate to the thymus is their potential to originate other
lineages. Besides T cells, these progenitors have the potential
to originate NK cells, dendritic cells, and B cells. Notch
signalling is necessary for T cell fate determination. M.
Braunstein and M. k. Anderson bring HEB (HeLa E box
binding factor) to the spotlight in the review about its role
in T cell commitment and transition through CD4−CD8−
stages of diﬀerentiation. Interestingly, HEB−/− DN3 thymo-
cytes can originate NK cells in the thymus. In the mouse
embryo, mature NK cells are found in the thymus, but
immature, therefore potential NK progenitors, are found in
the bone marrow, spleen, and liver. X. Wu et al. compare
the development of NK cells in the spleen and liver in
the mouse embryo. Their data show that the expression of
adhesionmolecules as CD11c and CD73 in liver NK cells may
account for the higher frequency of these cells in this tissue
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Figure 1: Schematic representation of lymphocyte development and activation. Development of lymphocytes takes place in primary
lymphoid organs as the bonemarrow (BM) and the thymus. Long-term hematopoietic stem cells (LTSCs) generate short-term hematopoietic
stem cells (STSCs), which in turn generate common myeloid and lymphoid progenitors (CMP and CLP, resp.,). T cell progenitor, migrate to
the thymus, where they undergo maturation through stages known as double negative (DN), representing CD4−CD8− cells, double positive,
and finally mature CD4+ or CD8+ T cells. Immature B cells leave the bone marrow to finish their development in the spleen, where they
progress through transitional stages 1 and 2 (T1 and T2) to generate mantle-zone B cells (MZ B cells), follicular B cells, or B1 cells. All mature
lymphocytes circulate through secondary lymphoid organs, where they are exposed to antigens, directly or through antigen presenting cells.
After the first stimulation by antigens, B and T cells migrate towards each other to interact in a process that will determine B cell antibody
production and T cell proliferation and further activation. The immunological synapses are represented between a dendritic cell and a naive
T cell and between primed B and T cells. In detail, one may observe molecules present in immunological synapses.
compared to others and that the liver microenvironment has
a role in NK diﬀerentiation. Focusing on the cell membrane,
instead of cytoplasmic and nuclear factors, as Bcl-xL and
HEB, B. Jin et al. review the role of the Toll like receptors
in T cell diﬀerentiation and activation. This review brings
information on the eﬀect of diﬀerent TLR ligands on T cell
development and the eﬀect of activation of diﬀerent TLRs in
antigen presentation, tolerance control, and T cell activation.
Regarding interaction with stroma of primary lymphoid
organs, R. Romano et al. review the role of FOXN1 in T cell
development and primary immunodeficiencies caused by its
altered expression in stromal cells in the thymus.
Once mature lymphocytes are generated, they migrate to
secondary lymphoid organs where they may encounter anti-
gens and depending on the conditions of this encounter, they
may be activated to generate eﬀector responses. Activation
of B and T lymphocytes displays some common and some
diﬀerent aspects. Both must recognize the antigen through
its B or T cell receptor. However, while BCR binds directly
to the antigen, the T cell receptor only binds to antigen
presented by antigen presenting cells through the Major
Histocompatibility Complex (MHC). This binding takes
place in a super structure called Immunological Synapse,
where adhesion molecules, costimulatory molecules, and
receptors, besides TCR and MHC, are present. Both types
of lymphocytes need more than the antigen to mount
an eﬃcient eﬀector response. For example, B cells may
respond to ligands of TLR besides BCR, and T cells have
receptors for costimulatory molecules presented by antigen
presenting cells, which are expressed upon proinflammatory
signals, as ligands for TLRs. Absence of a second stimulus
besides activation of BCR or TCR promotes the induction
of anergy or regulatory responses. Upon activation and
depending on signals presented to lymphocytes during
activation, these cells will diﬀerentiate into subtypes with
specific functions. CD4 T cells undergo diﬀerentiation into
CD4 helper phenotypes, as discussed in several articles in
this special issue. Already primed B cells may encounter
primed T cells and the communication between these two
lineages in the lymph nodes will promote isotype switching,
aﬃnity maturation, and proliferation in B cells, as well as
proliferation and further activation in T cells.
A. Visekruna et al. review the role of the transcription
factor NFκB in the T cell activation and eﬀector functions.
R. V. Luckheeram et al. discuss stimuli that promote CD4
T cell diﬀerentiation in the known T cell Th subtypes,
activation, and plasticity and eﬀector functions. With a very
diﬀerent approach, R. von Essen et al. discuss, in a broad
review, the concept of avidity maturation in T lymphocytes
and signals involved in such mechanism. As mentioned
before, for activation lymphocytes need at least two signals,
in this review, cytokines are considered the “third” signal
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to naive and primed T cell activation and diﬀerentiation.
Cell polarity in diﬀerent steps of T cell activation and
diﬀerentiation is discussed in the review by I. Fung et al., with
focus on GTPases, which are involved in cell migration in
several immune lineages, and the DOCK8 protein a Rho-Rac
guanine exchange factor.
During lymphocyte activation, diﬀerent stimuli will
influence the diﬀerentiation of memory cells, which are
important for the control of new infections by the same
pathogen. M. N. Norazmiet al. discuss the expression and
role of Peroxisome proliferator-activated receptor γ 1 and
2 (PPARγ) in human naive and memory T cells upon TCR
activation. Data presented by the authors suggest that the
two PPARγ isoforms may have diﬀerent roles during the
activation of naive and memory T cells.
Research on lymphocyte biology has a strong bias
towards clinical aspects and mechanism of several diseases,
from cancer to graft transplantation rejection to pathogen
immune responses. This special issue brings one article and
one review regarding inhibition of allograft rejection. Anti-
gen presentation and the role of B7 costimulatory molecule
in allograft rejection are explored in the article by Y. F. Yao
et al. Using an antisense B7 peptide, the authors were able
to inhibit T cell alloactivation and inhibit arterial allograft
intimal hyperplasia in a murine allogeneic carotid transplant
model. R. Wang et al. discuss a population that has been
actively studied in cancer, where it plays a protumoral role,
but that may be beneficial for the survival of allotransplants.
The myeloid derived suppressor cells are described and their
potential role in inhibiting cardiac allograft.
C. Wickenhauser et al. describe diﬀerent thresholds of
the activation of B cells by antigen and hapten in patients
with leukocyte adhesion-deficiency 1 (LAD1). Contrary
to immunodeficiency, patients with chronic C hepatitis
frequently develop thyroid disorders during IFNα therapy. Y.
Kajiyama et al. show that female patients with a higher serum
concentration of BAFF (B-cell-activating factor) display
significantly a higher risk of developing B cell dependent
thyroid disorders, as Graves disease and the production of
thyroid auto antibodies.
Finally, C. Schlimperet al. related their experience in
the generation of CIK (Cytokine Induced Killer cells) engi-
neering lymphocytes from colorectal carcinoma patients,
using the CAR chimera, chimeric antigen receptor, which
binds to the carcinoembryogenic antigen. Their data indicate
that this approach was successful in inducing patient T cell
proliferation and IFNγ production in an antigen dependent
manner.
This special issue covers several important aspects
of lymphocyte development, diﬀerentiation, and function
bringing relevant and up-to-date information in this area.
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